MARKET

XBI

XBI

SPDR® S&P Biotech ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

131.55
-1.93
-1.45%
After Hours: 131.49 -0.06 -0.05% 19:59 04/16 EDT
OPEN
134.55
PREV CLOSE
133.48
HIGH
134.56
LOW
130.02
VOLUME
7.10M
TURNOVER
--
52 WEEK HIGH
174.79
52 WEEK LOW
83.78
TOTAL ASSET
7.27B
YTD YIELD
11.79%
1D
5D
1M
3M
1Y
5Y
Behind the First Mutual Fund-to-ETF Conversion
Bloomberg · 2d ago
Ark Funds Snap Up $246 Million Worth of Coinbase Stock on Debut
Three funds at Cathie Wood’s Ark Investment Management bought shares of the biggest U.S. cryptocurrency exchange Coinbase Global Inc. on its highly anticipated trading debut Wednesday.
Bloomberg · 2d ago
Why a U.S. Bitcoin ETF Could Be a Real Thing in 2021
Looking for the adrenaline rush of investing in Bitcoin but without the bother of crypto-exchanges and digital wallets? An exchange-traded fund might do the trick, except an investor won’t find one tracking Bitcoin anywhere in the $6.1 trillion U.S. ETF un...
Bloomberg · 3d ago
First Inverse Bitcoin ETF to Debut for Betting on Crypto Plunge
Bloomberg · 3d ago
Bitcoin Approaches $65,000 With Coinbase Listing Fueling Demand
Bitcoin breached the $64,000 level for the first time as investor demand for all things crypto surged amid Coinbase Global Inc.’s public debut.
Bloomberg · 3d ago
Bitcoin ETF Drumbeat Gets Louder as Eight Issuers File With SEC
As Bitcoin hits records and Coinbase Global Inc. goes public, ETF issuers are betting en masse that U.S. regulators will green-light a fund tracking the largest cryptocurrency at long last.
Bloomberg · 3d ago
DJ Moderna Offers Update On Vaccine Program, To Launch Studies Of Flu, HIV Vaccine Candidates In 2021 -- MarketWatch
Dow Jones · 3d ago
Ex-BOJ Member Sakurai Sees No Rate Cuts Without Fresh Crisis
Bloomberg · 5d ago
More
No Data
Learn about the latest financial forecast of XBI. Analyze the recent business situations of SPDR® S&P Biotech ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-3.9149%
--
1-Week
-1.3327%
--
1-Month
-6.5522%
--
3-Month
2.3267%
--
6-Month
18.1541%
--
YTD
11.7862%
--
1-Year
35.5354%
--
3-Year
8.0603%
--
5-Year
8.1538%
--
10-Year
19.4995%
--
Since Inception
13.9739%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
SPDR® S&P Biotech ETF
Risk
Low risk
Inception Date
2006-01-31
Benchmark
NASDAQ Composite CR
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Feehily/Schneider/Donofrio